BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

uniQure N.V. (NASDAQ:QURE)

1 post

Biotech NewsuniQure (QURE) Skyrockets 248% on Huntington’s Data

  • BioTech Health X
  • September 26, 2025
uniQure N.V. (NASDAQ:QURE) is a pioneering gene therapy company with a rich history of advancing cutting-edge treatments designed…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • Praxis (PRAX) Plunges 37% After Tremor Drug Ulixacaltamide Trial Stopped for Futility
  • Jazz Pharma (JAZZ) Reports $905M R&D Charge, $505M Net Loss in Q2 2025
  • Harrow Health (HROW) Gains Momentum With $59 Cap on Out-of-Pocket Costs
  • uniQure (QURE) Skyrockets 248% on Huntington’s Data
  • Immuneering (IMRX) Reports 86% 9-Month Survival in Pancreatic Cancer
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • September 26, 2025
    Praxis (PRAX) Plunges 37% After Tremor Drug Ulixacaltamide Trial Stopped for Futility
    • September 26, 2025
    Jazz Pharma (JAZZ) Reports $905M R&D Charge, $505M Net Loss in Q2 2025
    • September 26, 2025
    Harrow Health (HROW) Gains Momentum With $59 Cap on Out-of-Pocket Costs
    • September 26, 2025
    uniQure (QURE) Skyrockets 248% on Huntington’s Data
    • September 25, 2025
    Immuneering (IMRX) Reports 86% 9-Month Survival in Pancreatic Cancer
Recent Posts
  • Qualigen Therapeutics (QLGN) Secures $41M Faraday Future Deal
    • September 25, 2025
  • BriaCell (BCTX) Raises $13.8M to Advance Cancer Immunotherapy Pipeline
    • September 25, 2025
  • PepGen (PEPG) Soars 96.8% After Breakthrough DM1 Results
    • September 25, 2025
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (1)
  • Biotech News (415)
  • Uncategorized (1)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top